- Home
- GUT vs INM Comparison
GUT vs INM Comparison
Compare GUT & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GUT
- INM
- Stock Information
- Founded
- GUT 1999
- INM 1981
- Country
- GUT United States
- INM Canada
- Employees
- GUT N/A
- INM N/A
- Industry
- GUT Trusts Except Educational Religious and Charitable
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- GUT Finance
- INM Health Care
- Exchange
- GUT Nasdaq
- INM Nasdaq
- Market Cap
- GUT N/A
- INM 3.2M
- IPO Year
- GUT N/A
- INM N/A
- Fundamental
- Price
- GUT $5.30
- INM $3.00
- Analyst Decision
- GUT
- INM
- Analyst Count
- GUT 0
- INM 0
- Target Price
- GUT N/A
- INM N/A
- AVG Volume (30 Days)
- GUT 176.3K
- INM 56.6K
- Earning Date
- GUT 01-01-0001
- INM 05-13-2025
- Dividend Yield
- GUT 10.93%
- INM N/A
- EPS Growth
- GUT N/A
- INM N/A
- EPS
- GUT N/A
- INM N/A
- Revenue
- GUT N/A
- INM $4,832,013.00
- Revenue This Year
- GUT N/A
- INM N/A
- Revenue Next Year
- GUT N/A
- INM N/A
- P/E Ratio
- GUT N/A
- INM N/A
- Revenue Growth
- GUT N/A
- INM N/A
- 52 Week Low
- GUT $4.60
- INM $1.72
- 52 Week High
- GUT $7.38
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- GUT 51.92
- INM 62.76
- Support Level
- GUT $5.13
- INM $2.56
- Resistance Level
- GUT $5.36
- INM $3.05
- Average True Range (ATR)
- GUT 0.15
- INM 0.27
- MACD
- GUT 0.01
- INM 0.09
- Stochastic Oscillator
- GUT 83.10
- INM 92.98
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.